On January 7, 2026, Jonathan Siegmann at Stifel Nicolaus published a new projection for Leidos, highlighting an anticipated upside of approximately 11.9% based on the firm’s review of upcoming contract awards in defense and healthcare IT. This adjustment reflects confidence in Leidos’ expanding backlog and the company’s success in securing multi-year government and civilian agency engagements.

Leidos currently holds a Zacks Rank of #2 (Buy), driven by a series of positive revisions to earnings estimates over the past three quarters. Analysts have lifted full-year revenue forecasts by an average of 4.2%, citing robust demand for cybersecurity solutions and systems integration services. This favorable outlook outpaces that of key competitors in the IT services space.

With a market capitalization of approximately 25.14 billion USD, Leidos stands among the largest pure-play technology services providers on the NYSE. Recent daily average trading volume reached over 1.1 million shares, underscoring strong liquidity and sustained investor interest during the firm’s latest earnings cycle.

Leidos secures its market position through a diversified portfolio spanning defense systems engineering, health information management, and aviation support. The company has reported a 12% year-over-year increase in its classified solutions segment and continues to ramp deliveries for a major multi-year healthcare modernization program. Its competitive advantage is bolstered by proprietary analytics platforms and longstanding agency partnerships.